Non-alcoholic fatty liver disease (NAFLD) is a common condition where fat builds up in the liver of people who drink little or no alcohol. It can lead to serious liver problems if not managed. Doctors are always looking for simple ways to spot who might be at risk. One promising tool is the TyG index, a number calculated from routine blood tests for triglycerides and blood sugar.
A new systematic review and meta-analysis combined data from many studies to see how well the TyG index and related measures predict NAFLD. The analysis included over 212,000 people from different studies. The results showed that people with higher TyG levels had much higher chances of having NAFLD. For example, when comparing the highest TyG levels to the lowest, the odds of NAFLD were more than four times greater.
The study also looked at combinations of the TyG index with body measurements like body mass index (BMI), waist circumference, and waist-to-height ratio. These combined indices also showed a link to NAFLD, but the connection was weaker. The TyG index alone seemed to be a stronger predictor.
However, the findings come with important caveats. The studies were observational, meaning they can show an association but cannot prove that high TyG causes NAFLD. There was also a lot of variation between studies, which lowers confidence in the exact size of the effect. More research is needed to confirm these results and to see if the TyG index can help guide treatment decisions.
Despite these limitations, the TyG index is a simple, inexpensive test that could help doctors identify people who might need further evaluation for NAFLD. It is not a replacement for other diagnostic methods, but it could be a useful screening tool. Patients with high TyG levels should talk to their doctor about their liver health and ways to reduce risk, such as diet and exercise.
In summary, this large analysis suggests that the TyG index is strongly linked to NAFLD. While more studies are needed, it may become a helpful part of routine health checks for fatty liver disease.